Industry Insights

AccurKardia, an ECG-led diagnostics software company focused on transforming ECG data into a more powerful diagnostic tool and broad biomarker to improve patient outcomes and save lives, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the commercial launch of its AccurECG Analysis System (v2.0) (K252361). AccurECG 2.0 builds on AccurKardia’s previously FDA-cleared AccurECG platform, representing the next-generation evolution of the company’s enterprise-grade ECG interpretation system. With this milestone, the AccurECG platform has now secured two separate FDA 510(k) clearances.

Mölnlycke Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the production of 100 million ProcedurePak trays at the company’s production sites in the Czech Republic.

A new study led by UNMC investigators shows that embedding a standardized glucose management protocol into the electronic health record (EHR) can help perioperative care teams better control blood sugar levels for patients with diabetes.

Aligning the lists will streamline safety event reporting and ultimately reduce reporting burden for clinicians, hospitals, and health systems. 

The results suggest that, in the future, a less traumatic alternative to open-heart surgery could become widely available for those at risk of coronary artery obstruction.

Summerlin Hospital Medical Center in Las Vegas recently made history as the first hospital in Nevada to earn the Comprehensive Heart Attack Center Certification from The Joint Commission.